Validation of an Allergic Rhinitis Control Test in Teenagers
NCT ID: NCT02818153
Last Updated: 2016-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2016-06-30
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this new study,the investigators propose, following exactly the same procedure as the pilot study of 2008, to confirme the validation of unmodified Adult questionnaire in adolescents 12 to 17 years inclusive.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917
Study Of Perennial Allergic Rhinitis In Pediatrics
NCT00253058
Perennial Allergic Rhinitis In Pediatric Subjects
NCT00257595
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
NCT00453583
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
NCT04915352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
questionnaire for allergic rhinitis control
Teenagers from 12 to 17 years old who complete a Self questionnaire regarding allergic rhinitis control during the consultation and after 15 days
Self questionnaire for allergic rhinitis control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self questionnaire for allergic rhinitis control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* parents formulated their study participation agreement by signing the consent form.
Exclusion Criteria
12 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital of Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9614
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.